[go: up one dir, main page]

AU7843094A - Methods for the reduction of postmenopausal ldl cholesterol - Google Patents

Methods for the reduction of postmenopausal ldl cholesterol

Info

Publication number
AU7843094A
AU7843094A AU78430/94A AU7843094A AU7843094A AU 7843094 A AU7843094 A AU 7843094A AU 78430/94 A AU78430/94 A AU 78430/94A AU 7843094 A AU7843094 A AU 7843094A AU 7843094 A AU7843094 A AU 7843094A
Authority
AU
Australia
Prior art keywords
postmenopausal
reduction
methods
ldl cholesterol
ldl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU78430/94A
Other languages
English (en)
Inventor
George W Creasy
William Olson
Frank Sacks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of AU7843094A publication Critical patent/AU7843094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU78430/94A 1993-09-23 1994-09-21 Methods for the reduction of postmenopausal ldl cholesterol Abandoned AU7843094A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12587493A 1993-09-23 1993-09-23
US125874 1993-09-23
PCT/US1994/010846 WO1995008329A1 (fr) 1993-09-23 1994-09-21 Procedes de reduction du ldl cholesterol post-menopausique

Publications (1)

Publication Number Publication Date
AU7843094A true AU7843094A (en) 1995-04-10

Family

ID=22421853

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78430/94A Abandoned AU7843094A (en) 1993-09-23 1994-09-21 Methods for the reduction of postmenopausal ldl cholesterol

Country Status (3)

Country Link
AU (1) AU7843094A (fr)
WO (1) WO1995008329A1 (fr)
ZA (1) ZA947406B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
JP2002534469A (ja) * 1999-01-18 2002-10-15 ノボ ノルディスク アクティーゼルスカブ エストロゲン及びデルタ−ゴナジエン−２１−オール−３，２０−ジオンの使用

Also Published As

Publication number Publication date
ZA947406B (en) 1996-03-22
WO1995008329A1 (fr) 1995-03-30

Similar Documents

Publication Publication Date Title
AU693059B2 (en) Joint mechanism for structural members
AU3658393A (en) Cholesterol lowering compounds
AU1956497A (en) Decontamination process
AU3723593A (en) Cholesterol lowering compounds
AU6570894A (en) Resuscitation apparatus
AU6904494A (en) Side panel assembly and method and apparatus for forming the same
AU4972196A (en) Shielding panel
AU3612093A (en) Cholesterol lowering compounds
AU7578094A (en) Methods for lowering serum cholesterol
AU3153895A (en) Floor panel
AU6253094A (en) Methods for the treatment of osteoporosis
AU1865497A (en) Method for the treatment of a liquid
AU5469894A (en) Panel
AU7702894A (en) Dolly
AU6256994A (en) P-dinitroso benzole
AU5657494A (en) New steroids
AU6516094A (en) Cholesterol 7-alpha hydroxylase expression regulation
AU3473193A (en) Treatment for atherosclerosis
AU7843094A (en) Methods for the reduction of postmenopausal ldl cholesterol
HK1000317B (en) Escalator apparatus
AU5886894A (en) Connection panel
AU6365294A (en) Two stage powder application method
AU5361494A (en) Cholesterol lowering compounds
AU2569095A (en) Panel
AU6984394A (en) Sterol compound